Current Edition

Current Features

Advancing Therapeutic Solutions with Antibody-drug Conjugates (ADCs)

As promising therapeutic agents for treating oncology indications, antibody-drug conjugates (ADCs) have become prominent in the biopharmaceutical market in recent ye...
Continue Reading →
Volume 15 Issue 3

Antibody Drug Conjugates and the Link to Fighting Cancer

Antibody drug conjugates (ADCs) are a big deal in oncology. And rightly so: they combine highly specific targeting with a potent cytotoxic payload to deliver tremend...
Continue Reading →